title: Staging and treatment response evaluation in a metastatic neuroendocrine tumor of the pancreas with G2 grading: insights from multimodality diagnostic approach by F-18-FDG and Ga-68-DOTANOC PET/CT.
authors.affiliation: Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Largo A. Gemelli 8, 00168, Rome, Italy. giorgiomednuc@libero.it
authors.forename: Giorgio
authors.initials: G
authors.lastname: Treglia
authors.forename: Francesca
authors.initials: F
authors.lastname: Plastino
authors.forename: Marco
authors.initials: M
authors.lastname: Campitiello
mesh_terms: D002945:Cisplatin / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008875:Middle Aged; D060787:Neoplasm Grading; D009367:Neoplasm Staging; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000556:secondary; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology; D010456:Peptides, Cyclic / Q000627:therapeutic use; D011877:Radionuclide Imaging; D013004:Somatostatin / Q000031:analogs & derivatives / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D010456:Peptides, Cyclic; C060347:lanreotide; D019788:Fluorodeoxyglucose F18; D013004:Somatostatin; D005047:Etoposide; D002945:Cisplatin